ASCO 2024 Annual Meeting-Chicago USA May 31-June 4, 2024   Comprehensive molecular profiling in newly diagnosed advanced high-grade ovarian cancer: unveiling BRCA 1/2 mutations and Genomic Instability Scores to advocate for public insurance coverage of genetic testing – Insights from the Hell...

ESMO Congress-Madrid Spain October 20-24, 2023   Testing HR+ / HER2- patients with advanced or metastatic breast cancer for identification of tissue mutations in the PIK3CA gene. Results of a national program by the Hellenic Society of Medical Oncology (HeSMO)   Αυτή η διεύθυνση ηλεκτρ...